Advertisement
Singapore markets close in 4 hours 1 minute
  • Straits Times Index

    3,294.92
    +22.20 (+0.68%)
     
  • Nikkei

    38,385.10
    +832.94 (+2.22%)
     
  • Hang Seng

    17,110.21
    +281.28 (+1.67%)
     
  • FTSE 100

    8,044.81
    +20.94 (+0.26%)
     
  • Bitcoin USD

    67,001.62
    +715.16 (+1.08%)
     
  • CMC Crypto 200

    1,436.96
    +22.20 (+1.57%)
     
  • S&P 500

    5,070.55
    +59.95 (+1.20%)
     
  • Dow

    38,503.69
    +263.71 (+0.69%)
     
  • Nasdaq

    15,696.64
    +245.33 (+1.59%)
     
  • Gold

    2,339.80
    -2.30 (-0.10%)
     
  • Crude Oil

    83.45
    +0.09 (+0.11%)
     
  • 10-Yr Bond

    4.5980
    -0.0250 (-0.54%)
     
  • FTSE Bursa Malaysia

    1,568.59
    +6.95 (+0.45%)
     
  • Jakarta Composite Index

    7,158.73
    +47.92 (+0.67%)
     
  • PSE Index

    6,572.32
    +65.52 (+1.01%)
     

Where Will AbbVie Be in 3 Years?

Where Will AbbVie Be in 3 Years?

In spite of market turmoil, this year has been bright so far for AbbVie (NYSE: ABBV). The company's star drug Humira continues to grow, and even reached the milestone of more than $20 billion in sales last year. Its other immunology drugs and the neuroscience business also are thriving.